Literature DB >> 20545477

Educational program for myofascial pain syndrome.

Shun-Yuan Lin1, Choo-Aun Neoh, Yuan-Ting Huang, Kuo-Yang Wang, Ho-Fu Ng, Hon-Yi Shi.   

Abstract

OBJECTIVE: The objective of this study was to evaluate a program for managing myofascial pain syndrome (MPS).
DESIGN: The study design was a randomized controlled trial.
SETTING: The setting was the pain clinic of an academic hospital in Taiwan. PARTICIPANTS: Sixty-two (62) patients with a 3-month or longer history of MPS who were treated at this institution from July to November 2007 were included in the study.
INTERVENTIONS: The participants were randomized to an experimental group (n = 32) or a control group (n = 30). Both groups underwent trigger-point dry needling and muscle-stretch exercise regimen for passively stretching the affected muscles to their normal lengths; the experimental group then watched an 8-minute multimedia instructional video about MPS with supplemental handouts. MAIN OUTCOME MEASURES: The Brief Pain Inventory-Taiwan was administered at baseline and 1 month thereafter. The effect size model was used to measure the effects of Brief Pain Inventory-Taiwan. Bootstrap estimation was used to derive 95% confidence intervals for group differences.
RESULTS: Compared to the control group, the experimental group had significantly less interference of pain, lower intensity of present pain, and least pain (p < 0.05). Multiple regression analysis of patients with shoulder pain revealed significantly improved pain intensity and interference of pain (p < 0.05).
CONCLUSIONS: The findings emphasize the importance of including patient education programs in MPS intervention.

Entities:  

Mesh:

Year:  2010        PMID: 20545477     DOI: 10.1089/acm.2009.0378

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  1 in total

1.  Comparisons of prediction models of myofascial pain control after dry needling: a prospective study.

Authors:  Yuan-Ting Huang; Choo-Aun Neoh; Shun-Yuan Lin; Hon-Yi Shi
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-18       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.